![Sheila Gujrathi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheila Gujrathi
Voorzitter bij
PROCESSA PHARMACEUTICALS, INC.
Vermogen: 4 M $ op 30-09-2026
Profiel
Sheila Gujrathi is een zakenman die Gossamer Bio, Inc. heeft opgericht en aan het hoofd heeft gestaan van 5 verschillende bedrijven. Dr. Gujrathi bekleedt de functie van voorzitter bij Turning Point Therapeutics, Inc., voorzitter van ADARx Pharmaceuticals, Inc., Chief Executive Officer van GB001, Inc. en Chief Executive Officer van GB006, Inc. Sheila Gujrathi zit ook in de raad van bestuur van Janux Therapeutics, Inc. In het verleden was zij President, Chief Executive Officer & Director bij Gossamer Bio, Inc., Vice President-Global Clinical Development Group bij Bristol Myers Squibb Co. en Chief Medical Officer bij Receptos LLC (een dochteronderneming van Bristol Myers Squibb Co.) en Franchise Team Leader bij Genentech, Inc. Zij behaalde een doctoraat en een bachelor aan de Northwestern University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-02-2026 | 112.639 ( 0,19% ) | 2 M $ | 30-09-2026 | |
| 07-08-2026 | 90.160 ( 0,28% ) | 2 M $ | 30-09-2026 |
Actieve functies van Sheila Gujrathi
| Bedrijven | Functie | Begin |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Directeur/Bestuurslid | 18-03-2021 |
| PROCESSA PHARMACEUTICALS, INC. | Voorzitter | 28-10-2026 |
| BLOSSOMHILL THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-05-2026 |
| BOLT BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 23-10-2026 |
Generian Pharmaceuticals, Inc.
 Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Voorzitter | 01-05-2023 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Consultant / Adviseur | - |
GB006, Inc.
 GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Algemeen Directeur | - |
Eerdere bekende functies van Sheila Gujrathi
| Bedrijven | Functie | Einde |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Voorzitter | 04-03-2026 |
| ADARX PHARMACEUTICALS, INC. | Voorzitter | 01-01-2025 |
| ░░░░░░░ ░░░ ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Sheila Gujrathi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
20
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 20 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
GB001, Inc.
 GB001, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
GB006, Inc.
GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Generian Pharmaceuticals, Inc.
Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Health Technology |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA therapeutics to treat diseases | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
